EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA

Jin Fan, Mengqi Zhuang, Wei Fan, Ming Hou

PeerJ · 2023

DOI: 10.7717/peerj.15706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Jin Fan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Insulin, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Major Research and Development Plan of Shandong Province, The ECCM Program of Clinical Research Center of Shandong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

N6-methyladenosine (m6A) methylation epigenetically regulates normal hematopoiesis and plays a role in the pathogenesis of acute myeloid leukemia (AML). However, its potential value for prognosis remains elusive.

Methods

Analysis of the datasets downloaded from The Cancer Genome Atlas and Genotype Tissue Expression databases revealed that the expression level of 20 regulators related to m6A RNA methylation differ between patients with AML and normal individuals. A prognostic risk model with three genes ( YTHDF3 , IGF2BP3 , and HNRNPA2B1 ) was developed using univariate Cox regression and the least absolute shrinkage and selection operator Cox regression methods.

Results

This established signature demonstrated good predictive efficacy with an area under the curve of 0.892 and 0.731 in the training cohort and the validation cohort, respectively. Patients with AML and an increased level of Insulin growth factor 2 mRNA binding protein 3 (IGF2BP3) expression exhibited a poor prognosis. IGF2BP3 knockdown significantly induced G0/G1 phase arrest and inhibited cell proliferation, apoptosis, and/or differentiation. Further, the JAK/STAT pathway may be involved in the regulation of EPOR expression by IGF2BP3 -mediated m6A RNA methylation.

Conclusion

These findings indicate that IGF2BP3 plays a carcinogenic role in AML, implying that it can predict patient survival and could be an effective strategy for AML therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinLeukemia, Myeloid, AcuteHumansAdenosineInsulin, Regular, HumanIntercellular Signaling Peptides and ProteinsJanus KinasesRNA, MessengerSignal TransductionSTAT Transcription FactorsRNA-Binding Proteins

Stichwörter der Autor:innen

Acute myeloid leukemiaEPORIGF2BP3JAK/STATm6A methylation

Substanzen

AdenosineInsulinInsulin, Regular, HumanIntercellular Signaling Peptides and ProteinsJanus KinasesRNA, MessengerSTAT Transcription FactorsIGF2BP3 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Qilu Hospital of Shandong University, Jinan, China.
  • The Fourth Hospital of Jinan, Jinan, China.
  • Department of Pharmacy and Medical Laboratory, Heze Medical College, Heze, China.

Förderung

  • The Major Research and Development Plan of Shandong Province
  • The ECCM Program of Clinical Research Center of Shandong University

Zitieren

APA

Fan, J., Zhuang, M., Fan, W., & Hou, M. (2023). RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA. PeerJ. https://doi.org/10.7717/peerj.15706

Vancouver

Fan J, Zhuang M, Fan W, Hou M. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA. PeerJ. 2023. doi:10.7717/peerj.15706

BibTeX
@article{Fan2023,
  author = {Fan, Jin and Zhuang, Mengqi and Fan, Wei and Hou, Ming},
  title = {RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15706}
}
Kostenlos starten →